STOCK TITAN

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

NeuroOne Medical Technologies (NMTC) will host a conference call and webcast on May 14, 2024, to discuss the financial results for its second quarter of fiscal year 2024 and provide a corporate update. The company focuses on improving surgical care options and outcomes for patients with neurological disorders.

Positive
  • None.
Negative
  • None.

EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on May 14, 2024 at 4:30 PM Eastern Time to discuss financial results for its second quarter of fiscal year 2024 ended March 31, 2024, and provide a corporate update.

Conference Call and Webcast Information:

Tuesday, May 14, 2024 – 4:30 PM Eastern Time

Participant Dial-In:
Toll Free: 888-506-0062
International: 973-528-0011
Access Code: 489972

Live Webcast: 
Join here.      

Phone Replay:
Toll Free: 877-481-4010
International: 919-882-2331
Replay Passcode: 50624
Available through May 28, 2024

Webcast Replay:
Available for 12 months

About NeuroOne

NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit nmtc1.com.

Contact:
800-631-4030
ir@nmtc1.com


FAQ

When will NeuroOne Medical Technologies report its second quarter fiscal year 2024 financial results?

NeuroOne Medical Technologies will report its second quarter fiscal year 2024 financial results on May 14, 2024.

What is the focus of NeuroOne Medical Technologies ?

NeuroOne Medical Technologies focuses on improving surgical care options and outcomes for patients suffering from neurological disorders.

What is the stock symbol of NeuroOne Medical Technologies ?

The stock symbol of NeuroOne Medical Technologies is NMTC.

NeuroOne Medical Technologies Corporation

NASDAQ:NMTC

NMTC Rankings

NMTC Latest News

NMTC Stock Data

29.12M
30.81M
10.22%
19.62%
0.42%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
EDEN PRAIRIE